On July 1, Align Technology rose 5.15% in regular trading, trading at $179.49/share, with turnover of $59.80 million. The stock staged a strong rebound after the prior session's selloff triggered by EU regulatory action.

On June 30, the European Union formally opened an antitrust investigation into Align Technology regarding its conduct in the Invisalign clear aligner and iTero intraoral scanner markets, examining whether the company may have abused its dominant market position to the detriment of competition and consumer interests. The news pressured shares down 2.75% to $168.66 that day. As the market digested the regulatory overhang, buyers stepped in to drive a recovery.

Fundamentally, the company reported Q1 adjusted EPS of $2.58, beating the consensus estimate of $2.28 by 13.16%, representing a 21.13% year-over-year increase. Revenue of $1.040 billion also exceeded the $1.022 billion estimate, providing underlying support for the rebound.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)